Implantable System for Remodulin Post-Approval Study
Stopped Implantable System for Remodulin not commercially approved.
Conditions
- Pulmonary Arterial Hypertension
Interventions
- COMBINATION_PRODUCT: Implantable System for Remodulin (treprostinil)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Collaborators